Purpose To determine the role of T cells and natural killer (NK) cells in mediating corneal xenograft rejection of a pig‐to‐mouse model. Methods Pig corneas were orthotopically transplanted to C57BL/6, Balb/c‐nu and CB.17 SCID mice with or without NK depletion. NK cells were depleted by an intraperitoneal injection of anti‐NK1.1 mAb three days before and one day after transplantation. Graft survival was clinically assessed by slit‐lamp microscopy, and median survival times (MST) were calculated. The rejected grafts were histologically evaluated. Results The pig corneal xenografts were acutely rejected by C57BL/6 mice (MST 7.00±0.61 days), while Balb/c‐nu and CB.17 SCID mice rejected pig corneas in more delayed fashion (MST 14.00±0.77 and 15.00±0.58 days, respectively). NK depletion failed to a further prolongation of the pig corneal xenograft survival in Balb/c‐nu mice. The rejected grafts in C57BL/6 mice were heavily infiltrated with inflammatory cells, the majority of which were macrophages. Many CD4+ T cells were observed, but either CD8+ T cells or NK cells were rarely found. In contrast, the grafts in Balb/c‐nu mice had markedly decreased inflammatory infiltration with small amounts of macrophages and CD4+ T cells, and the infiltration was further reduced in CB.17 SCID mice. Conclusion Acute rejection of the pig corneal xenografts in mice is not solely a consequence of an adaptive immunity although CD4+ T cells play an important role in the graft rejection. Other innate immune effectors than NK cells seem to be involved in the rejection of a pig‐to‐mouse corneal xenotransplantation.
Purpose To investigate the role of keratocytes in corneal innate immune system and cross‐talk of keratocytes with resident antigen presenting cells (APCs), especially through toll‐like receptor (TLR)2 and TLR4. Methods Firstly, primary cultivated C57BL/6 (B6) mouse keratocytes were stimulated by Pam3CSK4 (TLR2 agonist) or lipopolysaccharide (LPS; TLR4 agonist) and then were evaluated for their cytokine secretion. To demonstrate the cross‐talk between B6 keratocytes and APCs, cytokine changes under Pam3CSK4 or LPS challenge were assessed in co‐culture condition of B6 keratocytes with mouse dendritic cell line (DC 2.4) or mouse macrophage cell line (Raw 264.7). The reversal effect was checked out using keratocytes from TLR2 knockout (KO) or TLR4KO mice. Results Primary cultivated keratocytes from B6 mice per se actively secreted pro‐inflammatory cytokines, especially interleukin (IL)‐6, with a dose‐dependent manner in response to Pam3CSK4 or LPS challenge. With co‐culture of keratocytes with APCs, secretion of IL‐6 and tumor necrosis factor (TNF)‐α was markedly increased and it was counterbalanced by concurrent increase in IL‐10 and tumor growth factor (TGF)‐β1. After Pam3CSK4 or LPS stimulation, this cytokine balance was completely broken down by overwhelming amplification of IL‐6 and TNF‐α secretion, especially in co‐culture of keratocytes with macrophages, rather than with dendritic cells. Using keratocytes from TLR2KO or TLR4KO mice, we could find the reversal of Pam3CSK4 or LPS‐responsive dose‐dependent increment pattern in IL‐6 and TNF‐α. Conclusion These results implied that keratocytes and their TLRs could be key components for the ocular homeostasis and pathogen‐associated ocular innate immunity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.